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CONCLUSIONS
 Plasmids belonging to four major incompatibility groups (IncA/C, IncF,  IncI were identified using the 
PlasmidFinder database.  This database further subtyped the IncF plasmids into incFIB, IncFIB (S), 
IncFII (S) and the IncI plasmids into IncI1 and IncI2 (Table 1).
 pMLST database confirmed the subtyping of IncF and IncI plasmids on the basis of different alleles of 
select genes (Table 2).
 Several antibiotic resistance genes were identified using the ResFinder database.  Location of some 
of these genes directly corresponded with the location of the CMY2 plasmids.  For example, IncI1 
plasmid and blaTEM-18 gene are both found on contig 11 in CMY-039.   Other resistance genes were 
often found on adjacent or nearby contigs but not on the same contig as the different plasmids 
(Table 3)
 Plasmid sequences were found  located on multiple Contigs.  BLAST search results are currently 
being utilized to identify and align complete sequence of each plasmid. 
CMY-024 Locus % Identity Allele Length Allele
Incl1 pilL 99.61 254 pilL_2
CMY-030 Locus % Identity Allele Length Allele
IncF FII 100 215 FII_S1
FIB 100 373 FIB_1
CMY-032 Locus % Identity Allele Length Allele
IncF FII 100 215 FII_S1
FIB 100 373 FIB_17
CMY-037 Locus % Identity Allele Length Allele
IncF FII 100 215 FII_S1
FIB 100 373 FIB_1
CMY-038 Locus % Identity Allele Length Allele
IncF FII 100 215 FII_S1
FIB 100 373 FIB_17
CMY-039 Locus % Identity Allele Length Allele
Incl1 ardA 100 343 ardA_4
pilL 100 254 pilL_2
repI1 100 83 repI1_2
sogS 100 235 sogS_4
trbA 100 465 trbA_5
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ABSTRACT
Many Gram negative bacteria including Salmonella enterica species exhibit evolving multi-drug resistance coded for on their chromosome and on mobile 
genetic elements.  Salmonella species carrying multi-drug resistance plasmids can potentially disperse the cmy-2 gene conferring β-lactam resistance to new 
Salmonella species as well as to other enteric bacteria commonly found in the human and animal gut.  Objective: This study seeks to identify the numbers 
and incompatibility types of plasmids carried by six different Salmonella clinical isolates.  Design: Raw whole genome and DNA fragment (contig) sequence 
secondary data analyses were conducted using the Center for Genomic Epidemiology (Lyngby, Denmark) open source internet databases plasmid Multilocus 
Sequence Typing (pMLST) and Resistance Finder (ResFinder).  Method: Nucleic acid sequences were separated into files, labeled by contig, and uploaded to 
the consensus databases for analysis against known Salmonella resistance genes and plasmid types.  Results were returned in table format and identified 
specific resistance, susceptibility, and incompatibility groups present with greater than 90% homology between known and analyzed DNA sequences.  
Results: Results of this analysis show that these bacterial strains carry plasmids which confer multi-drug resistance and that multiple incompatibility groups 
are present across some but not all analyzed Salmonella strains.  Conclusions: The researchers continue to analyze the data and have not yet formed 
conclusions as to their significance.  This study will advance our understanding about how bacteria develop multiple antibiotic resistances and could 
ultimately help design more effective drugs with greater potential to combat and prevent bacterial diseases.
RESULTS
MATERIALS & METHODS
The Center for Genomiic Epidemiology (CGE) http://www.genomicepidemiology.org is a central database 
that continues to develop algorithms for rapid analyses of whole genome DNA-sequences, tools for analyses 
and extraction of information from the sequence data and internet/web-interfaces for using the tools in the 
global scientific and medical community.  Three of their tools were used in this study.
PlasmidFinder: This database Identifies plasmids including ones carrying antimicrobial resistance in total or 
partial sequenced isolates of bacteria (e.g. clinically important bacteria). The program can utilize raw, contig 
group, or completely assembled and closed plasmid sequencing data. The database currently consists of 116 
replicon sequences that match with at least at 80% nucleotide identity all replicon sequences identified in 
the 559 fully sequenced plasmids. 
Plasmid Multi-Locus Typing: Database developed to perform sequence-based subtype five plasmids very 
frequently isolated from clinically relevant enterobacterial strains.  These plasmids are IncF, IncN, IncHI2 and 
IncHI1.
ResFinder data analysis:  This database compares submitted whole genome sequence data to the known 
antibiotic resistance genes in the NCBI nucleotide database.  Results are reported as % identity to known 
resistance genes based on the number of nucleotides that match between the sequences.
National Center for Biotechnology Information https://www.ncbi.nlm.nih.gov BLAST (Basic Local Alignment 
Search Tool) is a tool that helps in finding regions of similarity between biological sequences by comparing 
nucleotide/protein sequences to sequence database and calculates the statistical significance.
Table 2.  Salmonella incompatibility groups with 
comparative allelic identities.
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Table 3.  Salmonella clinical isolate antibiotic resistances and their associated 
resistance genes.  Note: CMY-030 displayed no antibiotic resistance genes.
Contig Predicted phenotype Resistance gene %Identity
CMY-024 contig 1 Aminoglycoside resistance aph(3')-Ia 99.02
CMY-024 contig 2 Phenicol resistance floR 98.27
CMY-024 contig 2 Aminoglycoside resistance strA, strB, sul2 100
CMY-024 contig 2 Tetracycline resistance tet(A) 100
CMY-024 contig 14 Beta-lactam resistance blaCMY-2 100
CMY-024 contig 102 Tetracycline resistance tet(B) 100
CMY-032 contig 6 Beta-lactam resistance blaCMY-2 100
CMY-032 contig 20 Aminoglycoside resistance aadA2 100
CMY-032 contig 20 Trimethoprim resistance dfrA12 100
CMY-032 contig 20 Sulphonamide resistance sul1 100
CMY-032 contig 27 Phenicol resistance floR 98.27
CMY-032 contig 27 Aminoglycoside resistance strA, strB, sul2 100
CMY-032 contig 27 Tetracycline resistance tet(A) 100
CMY-032 contig 56 Aminoglycoside resistance aph(3')-Ia 99.4
CMY-037 contig 9 Beta-lactam resistance blaCMY-2 100
CMY-037 contig 9 Aminoglycoside resistance strA, strB, sul2 100
CMY-037 contig 18 Phenicol resistance floR 98.19
CMY-037 contig 29 Aminoglycoside resistance aph(3')-Ic 98.77
CMY-037 contig 30 Tetracycline resistance tet(A) 100
CMY-037 contig 35 Beta-lactam resistance blaTEM-1B 100
CMY-037 contig 36 Sulphonamide resistance sul1 100
CMY-037 contig 42 Aminoglycoside resistance aadA1 100
CMY-037 contig 43 Aminoglycoside resistance aadA2 100
CMY-037 contig 43 Trimethoprim resistance dfrA12 100
CMY-038 contig 9 Aminoglycoside resistance aadA2 100
CMY-038 contig 9 Beta-lactam resistance blaCMY-2 100
CMY-038 contig 9 Trimethoprim resistance dfrA12 100
CMY-038 contig 9 Sulphonamide resistance sul1 100
CMY-038 contig 16 Phenicol resistance floR 98.27
CMY-038 contig 16 Aminoglycoside resistance strA, strB, sul2 100
CMY-038 contig 16 Tetracycline resistance tet(A) 100
CMY-038 contig 61 Aminoglycoside resistance aph(3')-Ia 99.02
CMY-039 contig 11 Beta-lactam resistance blaTEM-1B 100
CMY-039 contig 53 Aminoglycoside resistance aph(3')-Ia 99.28
RESULTS CONT’D
Table 1.  Salmonella enterica plasmid types based on incompatibility groups and 
their location based on whole genome analysis.
